---

Accomplia was first marketed by the French pharmaceutical company Sanofi-Aventis , and despite attempts by the company to get Accomplia in circulation throughout the United States it failed due to rejection by the Food and Drug Administration in 2006. acomplia for sale The French company were not happy with the initial rejection so they wrote a response, but it was again rejected by the Endocrine and Metabolic Drugs Advisory Committee (EMDAC) in 2007. The committee stated that Accomplia was unsafe for use and the company had not provided sufficient information to prove Accomplia harmless.